Characterization of Three Promoter Elements and Cognate DNA Binding Protein(s) Necessary for IFN-γ Induction of gp91-phox Transcription

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2418-2429

  Eklund, Elizabeth A ^a,c   Luo, Wen ^a,b   Skalnik, David G ^a,b,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYBB PROTEIN, HUMAN; DNA BINDING PROTEIN; GAMMA INTERFERON; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BINDING SITE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION;

BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030587170     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:659.
2. Klebanoff, S. J. 1975. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin. Hematol. 12:117.
3. Lomax, K. J., T. L. Leto, H. Nunoi, J. I. Galin, and H. L. Malech. 1989. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245:409.
4. c-src. Science 248:727.
5. Royer-Pokora, B., L. M. Kunkle, A. P. Monaco, S. C. Goff, P. E. Newburger, R. L. Baehner, F. S. Cole, J. T. Curnutte, and S. H. Orkin. 1986. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322:32.
6. Orkin, S. H. 1989. Molecular genetics of chronic granulomatous disease. Annu. Rev. Immunol. 7:277.
7. Newburger, P. E., R. A. B. Ezekowitz, C. Whitney, J. Wright, and S. H. Orkin. 1988. Induction of phagocyte cytochrome b heavy chain gene expression by interferon γ. Proc. Natl. Acad. Sci. USA 85:5215.
8. Skalnik, D. G., D. M. Dorfman, A. S. Perkins, N. A. Jenkins, N. G. Copeland, and S. H. Orkin. 1991. Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc. Natl Acad. Sci. USA 88:8505.
9. Eklund, E. A., and D. G. Skalnik. 1995. Characterization of a gp91-phox promoter element that is required for interferon γ-induced transcription. J. Biol. Chem. 270:8267.
10. Tucker, K. A., M. B. Lilly, L. Heck, and T. A. Rado. 1987. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70:372.
11. 558. J. Clin. Invest 94:1205.
12. Kessler, D. S., D. E. Levy, and J. E. Darnell. 1988. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 85:8521.
13. Parrington, H., N. C. Rogers, D. R. Gewert, R. Pine, S. A. Veals, D. E. Levy, M. R. Start, and I. M. Kerr. 1993. The interferon-stimulable response elements of two human genes detect overlapping sets of transcription factors. Eur. J. Biochem. 214:617.
14. Skalnik, D. G., E. C. Strauss, and S. H. Orkin. 1991. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:16736.
15. Skalnik, D. G., D. M. Dorfman, D. A. Williams, and S. H. Orkin. 1991. Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol. Cell. Biol. 11:4518.
16. Vallette, F., E. Mege, A. Reiss, and M. Adesnik. 1989. Construction of mutant and chimeric genes using the polymerase chain reaction. Nucleic Acids Res. 17: 723.
17. Lew, D. J., T. Decker, I. Strehlow, and J. E. Darnell. 1992. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 11:182.
18. Weisz, A., P. Marx, R. Sharf, E. Appella, P. H. Driggers, K. Ozato, and B.-Z. Levi. 1992. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267:25589.
19. Fu., X.-Y., D. S. Kessler, S. A. Veals, D. E. Levy, and J. E. Darnell. 1990. ISGF3, the transcriptional activator induced by interferon α, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA 87:8555.
20. Eilers, A., M. Baccarini, F. Horn, R. A. Hipskind, C. Schindler, and T. Decker. 1994. A factor induced by differentiation signals in cells of the macrophage lineage binds to the gamma interferon activation site. Mol. Cell. Biol. 14:1364.
21. Hassanain, H. H., S. Y. Chon, and S. L. Gupta. 1993. Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-γ and -α: analysis of the regulatory region of the gene and identification of an interferon-γ-inducible DNA-binding factor. J. Biol. Chem. 268:5077.
22. Dorn, A., J. Bollekens, A. Staub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT box-binding proteins. Cell 50:863.
23. Tanaka, N., T. Kawakami, and T. Taniguchi. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531.
24. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347.
25. Gey, G. O., W. D. Coffman, and M. T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264.
26. Sambrook, J., E. F. Frisch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 9.31-9.57.
27. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
28. Brunelle, A., and R. Schleif. 1987. Missing contact probing of DNA-protein interactions. Proc. Natl. Acad. Sci. USA 84:6673.
29. Maxam, A., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499.
30. Barker, K. A., S. H. Orkin, and P. E. Newburger. 1988. Expression of the X-CGD gene during induced differentiation of myeloid leukemia cell line HL-60. Mol. Cell. Biol. 8:2804.
31. Ghosh, D. 1990. A relational database of transcription factors. Nucleic Acids Res. 18:1749.
32. Eisenbeis, C. F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377.
33. Steimle, V., C. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
34. Harada, H., M. Kitayawa, N. Tanaka, H. Yamamoto, K. Harada, M. Ishihara, and T. Taniguchi. 1993. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259:971.
35. Sharf, R., A. Azreil, F. Lejbkowicz, S. S. Winograd, R. Ehrlich, and B.-Z. Levi. 1995. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270:13063.
36. Vaughan, P. S., F. Aziz, A. J. Van Wijnen, S. Wu, H. Harada, T. Taniguchi, K. J. Soprano, J. L. Stein, and G. S. Stein. 1995. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 377:362.
37. Skalnik, D. G., E. C. Strauss, and S. H. Orkin. 1991. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:16736.
38. Willman, C. L., C. E. Sever, M. G. Pallavicini, H. Harada, N. Tanaka, M. L. Slovak, H. Yamamoto, K. Harada, T. C. Meeker, A. F. List, and M. L. T. Taniguchi. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968.